Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus

Table 1 Distribution of HBV and HCV markers in various population

Group	n	HBsAg		HBV DNA		Anti-HCV		HCV RNA
		n (%)		n (%)		n (%)		n (%)
Turkish soldiers	11234	243	(2.16)a	223	(1.98)	50	(0.45)	35	(0.31)
Civil donors	5057	154	(3.00)	150	(2.90)	23	(0.45)	13	(0.25)
Northern cyprus soldiers	1254	34	(2.71)	23	(1.83)	7	(0.56)	5	(0.39)
Total	17545	431	(2.46)	396	(2.25)	80	(0.46)	53	(0.33)

^aP = 0.047 vs the group of civil donors (groupII).

Table 2 Distribution of HCV genotyping in various population

Group	HCV RNA	Genotype 1b		Genotype 1a		Genotype 2
		n (%)		n (%)		n (%)
Turkish soldiers	35	34	(97.1)	1	(2.8)
Civil donors	13	11	(84.6)	1	(7.7)	1	(7.7)
Northern Cyprus soldiers	5	4	(80.0)	1	(20.0)
Total	53	49	(92.4)	3	(5.7)	1	(1.9)

Table 3 Distribution of HBV and HCV markers by gender

Group	n	HBsAg		Anti-HCV		Anti-HIV
		n (%)		n (%)		n (%)
Female	3999	88	(2.20)	15	(0.38)	0	(0)
Male	13546	343	(2.53)	65	(0.48)	0	(0)
Total	17545	431	(2.46)	80	(0.46)	0	(0)

Table 4 Distribution of HBV, HCV and HIV markers according to age group

Age group (yr)	Anti-HIV		HBsAg		Anti-HCV
	n	(%)	n	(%)	n	(%)
20-29	10352	(59.0)	222	(2.14)b	50	(0.48)
30-39	4532	(25.8)	142	(3.13)b	21	(0.46)
40-49	1432	(8.2)	49	(3.42)b	5	(0.35)
> 50	1229	(7.0)	18	(1.47)	4	(0.33)
Total	17545	(100.0)	431	(2.46)	80	(0.46)

^bP < 0.001 vs the group of older individuals (> 50 yr).